SOD2, superoxide dismutase 2, 6648

N. diseases: 668; N. variants: 32
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.370 AlteredExpression group BEFREE In conclusion, the expression of SOD2 was increased in CIN3 and SCC, and more increased in cervical ADC than in SCC. 29774090 2018
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.370 AlteredExpression group BEFREE A549 human lung epithelial adenocarcinoma cells were exposed to increasing concentrations (0.1‑10 µg/cm2) of particles and fibres for 24 h. Subsequently, the gene expression of X‑linked inhibitor of apoptosis (XIAP), superoxide dismutase (SOD)1 and SOD2 were analysed by reverse transcription‑quantitative polymerase chain reaction. 29693699 2018
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.370 AlteredExpression group BEFREE By performing quantitative real-time PCR, Western blot, and spectrophotometric measurements, we found an increase in SOD2 at expression and activity level in colonic adenocarcinomas (mRNA: 1.96-fold; protein: 1.41-fold, activity: 1.8-fold; P < 0.05). 24677319 2015
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.370 Biomarker group BEFREE Moreover, 65.4% of ADENO exhibited intense SOD2 staining. 21725155 2011
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.370 GeneticVariation group LHGDN Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer. 18582155 2008
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.370 GeneticVariation group BEFREE The SOD2 Val/Val genotype may increase the risk of NSCLC carried by XRCC1 and p53 polymorphisms, particularly for adenocarcinoma. 15534883 2004
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.370 Biomarker group CTD_human Proteomic analysis of intestinal epithelial cells expressing stabilized beta-catenin. 12907644 2003
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.370 AlteredExpression group LHGDN NF-kappaB-dependent MnSOD expression protects adenocarcinoma cells from TNF-alpha-induced apoptosis. 12032830 2002